NCT00587145

Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 44 (estimated)
• Sponsor: National Cancer Center, Korea · Other Government
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This study is an open-label, single center, and a single arm phase II study to evaluate the clinical response and safety of perioperative S-1 plus docetaxel. Perioperative chemotherapy is composed of 3 cycles of preoperative S-1/docetaxel and 3 cycles of postoperative S-1/docetaxel.Chemotherapy regimen: * S-1 80 mg/m2/day every 12-h p.o. on days 1(evening)-15 (morning) * Docetaxel 35 mg/m2 mixed in d5w 250 ml iv over 60-min on days 1 and 8

Conditions

• Stomach Neoplasms

Interventions

Type	Name	Description
DRUG	S-1,Docetaxel	* S-1 80 mg/m2/day every 12-h p.o. on days 1(evening)-15 (morning) * Docetaxel 35 mg/m2 mixed in d5w 250 ml iv over 60-min on days 1 and 8

Timeline

• Start date: 2006-05-01
• Primary completion: 2009-03-01
• Completion: 2009-05-01
• First posted: 2008-01-07
• Last updated: 2008-01-07

Locations

1 site across 1 country: South Korea